Do Analysts Agree Thursday on Silverback Therapeutics Inc (SBTX) Stock's Target Price?

Thursday, August 11, 2022 02:25 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Thursday on Silverback Therapeutics Inc (SBTX) Stock's Target Price?

InvestorsObserver is giving Silverback Therapeutics Inc (SBTX) an Analyst Rating Rank of 5, meaning SBTX is ranked higher by analysts than 5% of stocks. The average price target for SBTX is $4.25 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating SBTX a Hold today. Find out what this means to you and get the rest of the rankings on SBTX!

See Full SBTX Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Silverback Therapeutics Inc Stock Today?

Silverback Therapeutics Inc (SBTX) stock is trading at $5.11 as of 2:23 PM on Thursday, Aug 11, a gain of $0.08, or 1.59% from the previous closing price of $5.03. The stock has traded between $4.97 and $5.27 so far today. Volume today is below average. So far 132,805 shares have traded compared to average volume of 435,375 shares. Click Here to get the full Stock Report for Silverback Therapeutics Inc stock.